Sign up online today & collaborate
or click here to find out more
London, UK – Tiziana Life Sciences plc, a clinical stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, notes the passing of Professor Chris McGuigan on Friday 11 March 2016. Prof. McGuigan was a co-founder of Tiziana Life Sciences and was appointed as a Non-executive Director in January 2015.
Gabriele Cerrone, Chairman of Tiziana, said: “I was deeply saddened to learn of the passing of Professor Chris McGuigan. As well as being a close personal friend, Chris and I also collaborated together on several successful biotech ventures. The Board and I will miss his wise counsel and we send our heart-felt condolences to his family at this difficult time.”
|Company||Tiziana Life Sciences plc|